Accès gratuit
Numéro
Obésité
Volume 12, Numéro 3, Septembre 2017
Fertilité et obésité
Page(s) 259 - 263
Section Revue de presse / Press review
DOI https://doi.org/10.1007/s11690-017-0595-4
Publié en ligne 25 août 2017
  • Nguyen NT, Kim E, Vu S, Phelan M (2017) Ten-year outcomes of a prospective randomized trial of laparoscopic gastric bypass versus laparoscopic gastric banding. Ann Surg online first. doi:10.1097/SLA.0000000000002348
  • Nguyen NT, Slone JA, Nguyen XMT, et al (2009) A prospective randomized trial of laparoscopic gastric bypass versus lapa-roscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 250:631–41. doi:10.1097/SLA.0b013e3181b92480 [PubMed]
  • Golzarand M, Toolabi K, Farid R (2017) The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc online first. doi:10.1007/s00464-017-5505-1
  • Magouliotis DE, Tasiopoulou VS, Sioka E, et al (2017) Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg 27:1345–57. doi:10.1007/s11695-017-2595-8 [CrossRef] [PubMed]
  • Yormaz S, Yılmaz H, Ece I, Sahin M (2017) Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg online first. doi:10.1007/s11695-017-2803-6
  • Buchwald H, Estok R, Fahrbach K, et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–.e5. doi:10.1016/j.amjmed.2008.09.041 [CrossRef] [PubMed]
  • Briatore L, Salani B, Andraghetti G, et al (2010) Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obes Silver Spring Md 18:932–6. doi:10.1038/oby.2010.28 [CrossRef]
  • Peterli R, Wölnerhanssen BK, Vetter D, et al (2017) Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-Year outcomes of the prospective randomized Swiss Multicenter Bypass or Sleeve Study (SM-BOSS). Ann Surg 265:466–73. doi:10.1097/SLA.0000000000001929 [CrossRef] [PubMed]
  • Schauer PR, Bhatt DL, Kirwan JP, et al (2017) Bariatric surgery versus intensive medical therapy for diabetes - 5 year outcomes. N Engl J Med 376:641–51. doi:10.1056/NEJMoa1600869 [CrossRef] [PubMed]
  • Felsenreich DM, Kefurt R, Schermann M, et al (2017) Reflux, sleeve dilation, and Barrett's esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg online first. doi:10.1007/s11695-017-2748-9
  • Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445–54. doi:10.1056/NEJMoa0901836 [CrossRef] [PubMed]
  • Samama CM, Gafsou B, Jeandel T, et al (2011) Guidelines on perioperative venous thromboembolism prophylaxis. Update 2011. Short text. Ann Fr Anesth Reanim 30:947–51. doi:10.1016/j.annfar.2011.10.008 [CrossRef] [PubMed]
  • American Society for Metabolic and Bariatric Surgery Clinical Issues Committee (2013) ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 9:493–7. doi:10.1016/j.soard.2013.03.006 [CrossRef] [PubMed]
  • Borkgren-Okonek MJ, Hart RW, Pantano JE, et al (2008) Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis 4:625–31. doi:10.1016/j.soard.2007.11.010 [CrossRef] [PubMed]
  • Carlsson LMS, Sjöholm K, Karlsson C, et al (2017) Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol 5:271–9. doi:10.1016/S2213-8587(17)30061-X [CrossRef]
  • Rubino F, Nathan DM, Eckel RH, et al (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39:861–77. doi:10.2337/dc16-0236 [CrossRef] [PubMed]
  • Rydén L, Mellbin L (2012) Glucose perturbations and cardiovascular risk: challenges and opportunities. Diab Vasc Dis Res 9: 170–6. doi:10.1177/1479164112451581 [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.